Brief: Beyond Air’S Lungfit® PH Receives FDA Approval To Treat Term And Near-Term Neonates With Hypoxic Respiratory Failure

Beyond Air

28/06/2022 21:48

June 28 (Reuters) - Beyond Air Inc  XAIR.O :
    * BEYOND AIR’S LUNGFIT® PH RECEIVES FDA APPROVAL TO TREAT
TERM AND
NEAR-TERM NEONATES WITH HYPOXIC RESPIRATORY FAILURE
    * BEYOND AIR INC - BEYOND AIR COMMERCIAL TEAM WILL BE
ACTIVELY
WORKING WITH SELECT HOSPITALS BEGINNING THIS MONTH TO MAKE
LUNGFIT PH AVAILABLE
    * BEYOND AIR INC - BROADER U.S. HOSPITAL LAUNCH EXPECTED IN
FIRST
HALF OF 2023

Source text for Eikon:  ID:nGNX1NWZfS 
Further company coverage:  XAIR.O 

 ((Reuters.Briefs@thomsonreuters.com;))